Learn more about our proprietary technologies, including our computational platform based on network biology and our RNA interference platform for gene silencing.
HepNet™ Computational Platform
Biological complexity remains the biggest challenge in drug discovery and development. We strive to address the lack of biological understanding to unlock key unmet medical needs.
GalOmic™ RNAi Platform
RNAi medicines are next-generation therapeutics, and their design is markedly accelerated relative to traditional drug modalities because it is based on the human genetic code.
We are progressing a broad therapeutic pipeline of GalOmic™ RNAi therapies that selectively target novel genes, guided by insights from our HepNet™ Computational Platform.